Literature DB >> 34975860

Gut Immune System and the Implications of Oral-Administered Immunoprophylaxis in Finfish Aquaculture.

Po-Tsang Lee1, Fernando Y Yamamoto2, Chen-Fei Low3, Jiun-Yan Loh4, Chou-Min Chong5.   

Abstract

The gastrointestinal immune system plays an important role in immune homeostasis regulation. It regulates the symbiotic host-microbiome interactions by training and developing the host's innate and adaptive immunity. This interaction plays a vital role in host defence mechanisms and at the same time, balancing the endogenous perturbations of the host immune homeostasis. The fish gastrointestinal immune system is armed with intricate diffused gut-associated lymphoid tissues (GALTs) that establish tolerance toward the enormous commensal gut microbiome while preserving immune responses against the intrusion of enteric pathogens. A comprehensive understanding of the intestinal immune system is a prerequisite for developing an oral vaccine and immunostimulants in aquaculture, particularly in cultured fish species. In this review, we outline the remarkable features of gut immunity and the essential components of gut-associated lymphoid tissue. The mechanistic principles underlying the antigen absorption and uptake through the intestinal epithelial, and the subsequent immune activation through a series of molecular events are reviewed. The emphasis is on the significance of gut immunity in oral administration of immunoprophylactics, and the different potential adjuvants that circumvent intestinal immune tolerance. Comprehension of the intestinal immune system is pivotal for developing effective fish vaccines that can be delivered orally, which is less labour-intensive and could improve fish health and facilitate disease management in the aquaculture industry.
Copyright © 2021 Lee, Yamamoto, Low, Loh and Chong.

Entities:  

Keywords:  GALT; gut immunity; immune tolerance; immunoprophylaxis; immunostimulants

Mesh:

Substances:

Year:  2021        PMID: 34975860      PMCID: PMC8716388          DOI: 10.3389/fimmu.2021.773193

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


Introduction

Diseases have always been the “Achilles’ heel” of intensive farming, and that analogy is especially accurate for aquaculture. With the development of technologies and intensification of production, several sources of stress such as animal handling, poor water quality, and overcrowding can compromise the fish immune system (1), and the water of enclosed intensive system can serve as a medium that facilitates the horizontal transmission of pathogens in the cultured species (2). Farmed fish are constantly exposed to opportunistic pathogens that naturally inhabit the nutrient-rich culture water (3). As it is connected to the external environment, the gastrointestinal tract is considered one of the main sites of pathogen translocation (4, 5). The gastrointestinal tract is a multifaceted system with several roles that go beyond the absorption of nutrients (5). The recent advances unravel the intricate interactions between the intestinal microbiome, dietary intake, and gut local immune system, and in turn how it affects the host physiological responses and health. And the impairment of gut health has been directly linked to the rising susceptibility to enteric infections (6, 7). Aquaculture is the fastest-growing animal production industry and it leverages on practicability and profitability (8). Owing to high practicability and stress-free administration, oral supplements and vaccines that can ameliorate fish health has been gaining traction and popularity in research, and understanding of gut immune system paves the way to the development of the oral application. Researchers and farmers of fed-aquaculture (i.e., fish that rely on nutrient input from formulated diets) are allowed to manipulate the health of the finfish through the diets by either incorporating feed additives, drugs, or even vaccines (5). Several feed supplements have long been investigated (e.g., immunostimulants, immunonutrients, phytotherapeutics, etc.) and have been reported to enhance the intestinal health of an array of aquatic species. The uniqueness of how each of these orally administered interventions could ameliorate the physiological responses of the host, or how their mechanisms can inhibit pathogen proliferation, deserves to be appraised in a holistic view with the fish intestinal immune system, which ultimately prevents disease outbreaks and economic losses. In this review, a compilation of recent studies on intestinal immunology of farmed finfish will be interpreted and discussed, as well as the advent of orally delivered vaccines, and plant-based immunostimulants on fish intestinal health.

Gut Immunity

Regionalization of Gastrointestinal Tract

The gastrointestinal tract is a hollow muscular tube that connects a series of alimentary organs, starting at the buccal cavity to the rectum (9). It is a multifunctional system that is not restricted only to digestion, but also nutrient absorption and sensing, water and electrolyte balance, hormone secretion, and the more challenging task to establish immunity (10). Although teleosts exhibit great heterogeneity in terms of morpho-histology of the gastrointestinal tract (11), the gut structure can be separated into three segments (12, 13). The first segment, commonly known as the foregut or anterior gut, is a topographical region of the gastrointestinal tract where the chemical digestion of ingested food matters begins (14). In this segment, the absorption of dietary protein takes place by enterocytes or intestinal absorptive cells (13). As the longest portion of the gut (9) and the site for the majority of digestive activities (15), the second segment or the midgut possesses enzymes from the pancreas, liver and intestinal wall to catalyze digestion and uptake of macromolecules (16). The midgut harbors highly diverse microbial consortia that are believed to take part in the digestion (17). Commonly termed as the hindgut, the third segment of the gastrointestinal tract is engaged in osmoregulatory activities such as ion transport and water reabsorption (13). Some studies described the teleost hindgut as homologues to the mammalian large intestine (18). As nutrient uptake progressively reduces (14) along the intestinal tract, the importance of immune homeostasis mechanisms gradually increases from the foregut to the hindgut segments (19). These trends have been supported by the higher transcript levels of immune-related genes along with the appearance of smaller irregular intestinal folds from the foregut to the hindgut (20, 21). Unlike mammals, separations or transitions between the different functional segments of the teleost gut are not clearly defined (18). The trichotomous division of the teleost gut into segments is obscure and inconsistent in research. For instance, some studies defined the proximal region of the intestine immediately after the stomach and pyloric ceca as the foregut (22–25), whereas others considered the stomach as the foregut (9, 26). It should be noted that there are studies that have categorized the entire gut into two segments instead of three (fore, mid and hind); therefore, the third gut segment was neglected or not recognized in these studies (9, 12). Some studies conducted with Atlantic salmon (Salmo salar) had divided the intestine into the mid and posterior regions, where the mid-intestine region was further subdivided into two, termed the first and second segments of the midgut (18, 20, 27). For the agastric fish, the entire gut (after the oesophagus) is divided into segments of equal length, e.g., 4 equal segments in ballan wrasse (Labrus bergylta) and 7 equal segments in zebrafish (Danio rerio). Segment 1, segments 2 - 3, and segment 4, represent the foregut, midgut, and hindgut of ballan wrasse, respectively (28). In zebrafish, segments 1-5 exhibits foregut/midgut features, whereas the segment 6 and 7 behave like the hindgut (19).

Gut-Associated Lymphoid Tissue

As one of the major parts of mucosal lymphoid tissues that are constantly connected with external environment and could be primary entry sites of pathogenic intrusions, fish gut-associated lymphoid tissues (GALTs) play an indispensable role in fish health (29). Unlike mammalian GALTs that possess organized structures such as mesenteric lymph nodes and Peyer’s patches (9), teleosts have diffusely organized GALTs that accommodate abundant myeloid and lymphoid cells, which regulate homeostasis to protect the host from potentially pathogenic microbes and to tolerate anodyne food-derived antigens and commensal microbiota (9, 30). All segments of the gastrointestinal tract comprise four concentric layers. From the outer lining of the gut inwards, these layers are: the serosa, the outermost of the gut that consists of a thin coating of squamous epithelium and connective tissue; the muscularis, a deeper layer consisting of muscle fibre sheets; the submucosa, might be absent completely in some teleost species such as zebrafish, is a concentric layer that is made up of loose connective tissues; and the mucosa, the innermost layer that acts as a physical-chemical barrier towards intestinal lining, and it is where the diffusely organised GALTs reside (9, 18, 31). Unlike the mammalian mucosa, the finger-like mucosal villi are absent in the teleost intestinal lining. The fish intestinal lining possesses intestinal folds that consist of a monolayer of columnar epithelium on the microvilli’s cell surface (18). The gut epithelial layer acts as an intrinsic physical layer that defends the host from the invasion of the harmful antigens (5). The epithelium expresses a wide spectrum of bioactive soluble factors, such as antimicrobial peptides, signaling molecules and toxin-neutralizing enzymes such as alkaline phosphatase. These defense molecules are also present in the mucus produced by intraepithelial goblet cells (32). Moreover, mucus harbors a high volume of mucins that cause the viscous nature of mucus. This glycoprotein dissociates microbes and impedes microbial adherence to the fish mucosa. Together with the epithelial layer, the extrinsic barrier conferred by the mucus protects the GALTs from the hostile environment of the gastrointestinal tract (9). The GALTs ( ) comprise two main leukocyte populations: (1) intraepithelial lymphocytes (IELs), which refer to the adaptive lymphoid cells that reside in the epithelial layer; (2) lamina propria leukocytes, which are consisting of lymphocytes, macrophages, granulocytes and dendritic-like cells (12, 33). The IgT+ B-cells have been reported as the predominant IELs in carp and sea bass (13, 34), whereas the IELs are primarily CD8-α+ cells (Cytotoxic T-cells) in sea bass (35).
Figure 1

Gut-associated lymphoid tissues (GALT) of finfish. Fish gut possesses diffusely organized GALTs that comprise two main leukocyte populations. Firstly, intraepithelial leukocytes, which mostly consisted of IgM+ B-cells, cytotoxic T-cells, and macrophages. Secondly, the lamina propria leukocytes, which are consisting of lymphocytes, macrophages, granulocytes and dendritic-like cells. Subpopulations have been reported in teleost cytotoxic T-cells, macrophages, and helper T-cells.

Gut-associated lymphoid tissues (GALT) of finfish. Fish gut possesses diffusely organized GALTs that comprise two main leukocyte populations. Firstly, intraepithelial leukocytes, which mostly consisted of IgM+ B-cells, cytotoxic T-cells, and macrophages. Secondly, the lamina propria leukocytes, which are consisting of lymphocytes, macrophages, granulocytes and dendritic-like cells. Subpopulations have been reported in teleost cytotoxic T-cells, macrophages, and helper T-cells. The IgT+ B-cells release antibodies of the IgT isotype, which acts as mucosal-associated antibodies to coat teleost luminal microbiota, analogous to mammalian IgA and amphibian IgX (34). IgT appears to be the ortholog of IgZ as these molecules are similar in structure and genome information (36). Two subclasses of IgZ have been identified in zebrafish, namely IgZ and IgZ2 (37). Functional analysis revealed that the IgZ antibodies activate complement-mediated lysis and the IgZ2 antibodies are unable to trigger complement activity but can coat and neutralize the microbes of the zebrafish gut, in turn, prevent microbial translocation across the epithelium (36). The CD8-α+ cells are another IEL in the fish gut. The cluster of differentiation 8 alpha (CD8-α) is a receptor expressed by the teleost cytotoxic T-cells. In addition to CD8-α, teleost intraepithelial cytotoxic T-cells bear T-cell receptors of the γδ heterodimers (TRγδ) that act like pattern recognition receptors (PRRs) to recognize antigen in a more non-specific manner in contrast to the systemic CD8-α+ cells that express αβ T-cell receptors (TRαβ) (38). The latter binds to major histocompatibility complex (MHC)-bound antigens specifically (39). Based on a molecular study that showed the gene expression of mhc-Iα and cd8-α of sea bass (Dicentrarchus labrax) intestine were not correlated, it has been postulated that fish intraepithelial CD8+ cells are able to recognize antigens without association with MHC molecules (35, 38). The innate immune features continue to be found on the teleost γδ T cells as a study of zebrafish (40) demonstrated that these IELs are capable of performing non-specific phagocytosis toward both particulate and soluble antigens, and in turn act as antigen-presenting cells to activate adaptive immunity, including IgZ B-cells. In addition to IELs, macrophages have been reported to be in epithelial compartments of some teleost species (38). Adjacent to the intestinal lumen, the epithelium-associated macrophages are specialized in scavenging and phagocytosing apoptotic epithelial cells and potentially harmful microbes (41). Mucosal macrophages also reside in the teleost lamina propria and intestinal muscularis. While the lamina propria macrophages function as antigen-presenting cells and cytokine producers to moderate local immune protections, the recently discovered muscularis macrophages are highly innervated and may play motility-oriented and neuroprotective roles in the teleost enteric nervous system, albeit their functional significance across multiple layers of the muscularis remain not clear (41). A study on zebrafish showed that mucosal macrophages can shape the intestinal microbial composition through the expression of interferon regulatory factor irf8 (42). An ineffective complement system followed by severe dysregulation of commensal microbiota was found in the adult irf8-deficient zebrafish. Akin to the mammalian macrophage, the bony fish have two subsets of macrophages: proinflammatory macrophages termed as M1 that produces TNF-α, and anti-inflammatory macrophages named as M2 and they are inept at producing TNF-α (43). These two macrophage subgroups are differentiated and polarized by distinct microenvironmental factors, where M1 is committed to the establishment of the inflammatory process and M2 is involved in the repair activity during the resolution phase of inflammation (44). Within the lamina propria, which is the underlying immune-rich connective tissue beneath the epithelial layer, tissue granulocytes can be found disseminated throughout the teleost gut. Similar to other phagocytic cells such as macrophages and dendritic-like cells, teleost granulocytes carry pattern recognition receptors to sense the presence of intruding pathogens through microbe-associated molecular patterns (32). Upon detection of a pathogen, immune protective responses are immediately taken place by the granulocytes through phagocytosis. The activated granulocytes will then produce histamine and chemokines that promote vasodilation of intestinal blood vessels and leukocyte infiltration (38). To protect the host from pathogens, neutrophils, which are a subset of fish granulocytes, release a vast array of bactericidal molecules such as antimicrobial peptides, peroxidase enzymes, reactive oxygen and nitrogen intermediates (45). Neutrophils are among the granulocytes that can readily infiltrate the teleost epithelium despite their low abundance in the teleost gut (38). Mast cells, also known as eosinophilic granular cells, are the granulocyte subpopulation that is functionally analogous to mammalian mast cells and highly vigilant against microbial intrusion through the fish mucosal barrier (18). Upon activation by sensing pathogenic invasion, teleost mast cells perform cell degranulation (38) and produce mediators of inflammation (46). Teleost mast cells have been found to mobilize and degranulate in response to parasitic infections in the gut (47). Teleost lamina propria houses a great diversity of cellular components of the adaptive immunity necessary for a local defensive response. All the aforementioned lymphocytes that exist in the epithelium as IELs, namely the IgT+ B-cells and cytotoxic T-cells, can also be found in the teleost lamina propria (13, 38). In addition to these cells, the other lymphocyte subsets have been reported in the lamina propria of the bony fish, including IgM+ B-cells, IgD+ B-cells, CD8α+ cytotoxic T-cells, helper T-cells, and regulatory T-cells (9, 48). Hitherto studies have revealed that teleost fish cannot perform immunoglobulin class switching (49). All B-cells can express two forms of immunoglobulins: (1) B-cell receptor, which is a membrane-bound immunoglobulin that serves as a receptor for specific pathogen targeting; (2) antibody, which is the secreted immunoglobulin form that is produced by activated and differentiated B-cells, known as plasma cell or plasmablasts (13). The activated B cells can migrate in the gastrointestinal epithelial layer after antigenic stimulation (34, 50). The phagocytic ability of B-cells has been reported in some species (51, 52). Teleost B-cells can express three heavy immunoglobulin chain isotypes, i.e., IgM, IgD, and IgT/IgZ (13), encoded by genes μ, δ, and τ/ζ, respectively (53). Although the function of IgT/Z antibodies has been elucidated elsewhere in the review, IgM antibodies that were previously perceived as the systemic adaptive humoral defense, have been found to coat mucosal resident microbes, albeit at a lower rate than the IgT antibodies (13). The binding of IgM antibodies to the corresponding targets initiates the complement-mediated lysis via the classical pathway, opsonization and agglutination of pathogens that facilitate pathogen clearance by phagocytes, blocking off the microbial active site, as well as neutralization of pathogen-derived toxin (54). The IgD B-cells are still an enigmatic B-lymphocyte subset as many relevant studies appear inconsistent in terms of cell lineage and function. For instance, rainbow trout IgM+ cells were found to co-express the IgD heavy chain (52, 55), but a unique IgM-/IgD+ B-cell population was reported in rainbow trout (Oncorhynchus mykiss) (56) and channel catfish (Ictalurus punctatus) (57). Functional studies have postulated that teleost IgD may be involved in mucosal homeostasis (55, 58, 59) as this immunoglobulin is produced to coat some gastrointestinal commensal bacteria (55, 59). However, rainbow trout IgD has been reported to be uninvolved in specific immunity in the mucosal organs during parasitic infestation (13). Due to divergence in findings, the immune function of teleost IgD remains mostly unclear and still inconclusive (13). Unlike the intraepithelial layer that bears only CD8-α+ γδ cytotoxic T-cells, the teleost gut lamina propria possesses both the CD8-α+ T-cell populations of TRγδ and TRαβ (38, 60). CD8-α+ cells of TRαβ bind to intracellular pathogen-derived antigens that are presented by the MHC class I molecules expressed on the target cell and differentiate into activated effector cells to lyse the target cells (60). CD4+ helper T-cells can be found in the teleost gastrointestinal lamina propria. This cell expresses T cell receptors and the cluster of differentiation 4 (CD4) on its surface for specific antigen recognition. In most reported teleost species, in exception to the gadoid line, antigen-presenting cells present antigenic peptides via the MHC-II and activate naive helper T-cells to make them proliferate into effector cells that produce inflammatory cytokines (32). These antigen-presenting cells include macrophages, granulocytes, dendritic-like cells as well as B-cells, and they release co-stimulatory molecules to prime helper T-cells (18, 32). Activated helper T-cells generate a cytokine cascade to coordinate and enhance host immune responses. These cells release IFN-γ to mediate teleost cellular defense, which involves the enhancements of CD8+ cell-mediated cytotoxicity and phagocytosis by macrophages (61). Humoral-mediated immunity can be elevated by teleost helper T-cells by regulating B-cell immune response (62). To date, few major types of helper T-cells have been reported in fish, namely CD4-1+ single-positive cells, CD4-2+ single-positive cells (63) as well as CD4-1+/CD4-2+ double-positive cells (44). And two subtypes of CD4-2, i.e., CD4-2a and CD4-2b, have been reported in brown trout (64). Expression levels of CD4-1, CD4-2a, and CD4-2b were recorded to be different in the same tissues of rainbow trout against antigenic stimulation (64, 65). While CD4-1+ cells have been revealed to play a pivotal role against viral diseases in ginbuna crucian carp (Carassius auratus) (62), a study using olive flounder as the animal model showed that CD4-2 helper T-cells proliferated earlier and higher in number than CD4-1 cells (66), suggesting that CD4-2 cells are important in the early phase of cell-mediated immunity. Regulatory T-cells are a subset of CD4-1+ cells in zebrafish (44, 67). A study on zebrafish (67) uncovered that the gut-derived CD4-1+ cells that were expressing the foxp3a and il-10 genes, which are gene signatures for the regulatory T-cells. Studies have defined foxp3acells as the regulatory T-cells in fish due to the notion that the foxp3a is a regulatory factor involved in the immunosuppressive machinery, which includes suppressing cell proliferation and cytokine production of leukocytes (68, 69). Fish regulatory T-cells, known as foxp3acells, promote an anti-inflammatory response that restrains the over-exhaustive activities toward the mucosal non-self-antigens during steady-state, preventing an autoimmune disorder, and mobilizing to the damaged region to release tissue-specific regenerative factors that stimulate the proliferation of regeneration precursor cells (69).

Absorption and Uptake of Antigens

Two major pathways of antigen uptake through the intraepithelial layer have been described in the mammal, i.e., the paracellular and transcellular routes. The paracellular pathway refers to the rate-limited passive transport of inert or mostly cationic antigens, typically smaller than 600 daltons, through the tight junctions between the epithelial resident cells (18). Although it has been postulated that exogenous antigens can cross the fish epithelium through this route in the steady-state condition, to date, no study provides conclusive evidence to this hypothesis (18, 38). The transcellular transport of exogenous antigen across teleost epithelial barriers depends on the physical nature of the antigen ( ). Fluid phase uptake of soluble antigens such as ferritin has been proven to take place via non-specific pinocytosis in grass carp (Ctenopharyngodon idella) and rainbow trout (38, 70–72). For small solid particles (<0.5 μm), as exemplified by HRP, solid-phase uptake by receptor-mediated endocytosis has been reported in the fish gut (18, 73). For larger particulate antigens, uptake can occur via phagocytosis, where the antigens are surrounded and internalized by the protrusion of cell membrane forming phagosomes (18, 74).
Figure 2

Antigen uptake in the gut. Their mechanisms of transcellular transport for exogenous antigens across teleost epithelial barriers have been described, namely fluid-phase uptake of soluble antigens by enterocytes via non-specific pinocytosis in carp and rainbow trout; solid-phase uptake of small solid antigens (<0.5 μm) by receptor-mediated endocytosis, and phagocytosis of larger particulate antigens. It has been proposed that the internalized antigens are processed in the endosome by merging with lysosomes containing enzymes, followed by systemic vascular release and transfer of the processed antigens to the intraepithelial or lamina propria antigen-presenting cells, viz. macrophages, some fish enterocytes expressed MHC-IIβ, which indicates that this cell might directly be serving as an antigen-presenting cell to activate the adaptive cells (35).

Antigen uptake in the gut. Their mechanisms of transcellular transport for exogenous antigens across teleost epithelial barriers have been described, namely fluid-phase uptake of soluble antigens by enterocytes via non-specific pinocytosis in carp and rainbow trout; solid-phase uptake of small solid antigens (<0.5 μm) by receptor-mediated endocytosis, and phagocytosis of larger particulate antigens. It has been proposed that the internalized antigens are processed in the endosome by merging with lysosomes containing enzymes, followed by systemic vascular release and transfer of the processed antigens to the intraepithelial or lamina propria antigen-presenting cells, viz. macrophages, some fish enterocytes expressed MHC-IIβ, which indicates that this cell might directly be serving as an antigen-presenting cell to activate the adaptive cells (35). In higher vertebrates, the transcellular route can be accomplished by epithelium M-cells, dendritic cells and goblet cells (18). Most of the bony fish studies evinced that the luminal antigen uptake was attributed to the regular enterocyte, which is also known as the epithelial cell, with antigen absorptive ability (12, 18). In enterocytes, antigens are internalized into large supranuclear vacuoles (endosomes) merged with lysosomes containing enzymes, followed by systemic vascular release and transfer of processed antigens to intraepithelial or lamina propria macrophages (38, 71, 75). It has been proposed that the mechanism of this transfer is akin to the mammalian melanin transfer process in the retina (12). To date, the mechanism of the antigen transfer is yet to be elucidated. Sea bass epithelial cells express MHC-IIβ, which indicates that this cell might be directly serving as an antigen-presenting cell to activate the adaptive branch of the mucosal immune system (35). The existence of M-cells and dendritic cells in the teleost gut is controversial. Absorptive cells that resemble mammalian M-cells functionally and phenotypically have been reported in the salmonid mid intestine (21, 27, 76, 77). These fish M-like cells can uptake bovine serum albumin (27), but cannot internalize inactivated bacteria (76). Different from mammalian mature M-cells, fish M-like cells do not possess intraepithelial pockets, and thus they are thought to be morphologically similar to mammalian immature M-cells (18). On the other hand, dendritic-like cells have been described in trout (78, 79) and zebrafish (80). These cells match mammalian dendritic cells’ hallmarks, such as activation by toll-like receptor-ligands, expression of gene signatures such as cd83, il-1β, il-10r, and il-12 p40, in vivo mobilization ability, phagocytosis ability of foreign particles, as well as the tree-like appearance (78, 81). Trout dendritic-like cells are found to express CD8α, a coreceptor of the cytotoxic T-cell (79). Localization of antigen absorption varies among teleost species. Mucosal antigen uptake has been described in the posterior gut of European sea bass (Dicentrarchus labrax) (82), the second segment of the carp gut (12), the second segment of the salmonid midgut (83), the trout stomach and hindgut (84), the ballan wrasse (Labrus bergylta) posterior gut (85), and the Atlantic cod (Gadus morhua) rectum (86).

Oral Immune Tolerance

Oral immune tolerance is a state of immunological unresponsiveness toward particular mucosal antigens, which may be due to the prevention of aberrant or excessive immune reactions to food-derived antigens or intestinal commensal microbiota, or ascribable to prior exposure to the same antigens (87). The physical-chemical barrier conferred by the GALT wards off the undesired pathogenic invasion, but also restrict the bioavailability of oral immunoprophylaxis to reach the gut inductive site for initiating local immunization. Low bioavailability of immunoprophylaxis-derived antigens is perilous as it may induce oral immunotolerance (88). Repetitive exposure to the same antigens may induce oral tolerance. Repeated anal intubation of allogeneic cells reduced specific cytotoxicity of T-cells in carp (89, 90). Pre-exposure of fish intestinal epithelial cell line (RTgutGC) to lipopolysaccharides (LPS) strongly impeded the immunostimulatory secondary response to the LPS. Similarly, pre-treatment of a fish spleen-derived monocyte-macrophage cell line (RTS11) with LPS also lowered the transcription of cytokines. Such immune tolerance effect was not observed in both cell lines treated to the repetitive exposures to β-glucans (87). Furthermore, prolonged exposure to orally administered antigens is another possible reason to evoke immunological tolerance (72). A study on β-glucan observed that a gradual down-regulation trend in immune gene expressions of the rainbow trout that was fed with the immunostimulant for 30 consecutive days, as compared to the gene expression levels recorded after the 15 consecutive days of post-feeding (91). The mechanistic details of teleost oral immune tolerance remain unclear (18). It has been proposed that two major mechanisms may be involved: (1) induction of regulatory T-cells, which is often associated with repetitive exposures to the low dosage of antigen; (2) anergy or deletion, which is linked to the antigen exposure of high dose (92). In mammalian models, mucosal T-cells have been shown to produce anti-inflammatory cytokines, particularly IL-4/13, IL-10, and TGF-β, which can induce immunosuppression and oral immune tolerance (18). These anti-inflammatory cytokines activate regulatory T-cells that eventually promote tolerance (76). The foxp3, a transcription factor expressed by activated regulatory T-cells, is the key marker of oral immune tolerance provoked by prolonged exposure to the same mucosal antigens. This mechanism of oral immune tolerance is termed as the induction of regulatory T-cells. In this mechanism, elevation in the foxp3 expression level is an indicator of oral tolerance in fish (93). On the other hand, oral tolerance can be induced by T-cell anergy and apoptosis. Although this mechanism has not yet been elucidated, it has been proposed to be associated with overfeeding the antigen. The anergy or apoptosis of T-cells stimulates the production of TGF-β (92). Thus, in this mechanism, TGF-β is said to be the indicator of oral immunosuppression. The upregulation of the genes for foxp3, il-10, and tgf-β was observed in Atlantic salmon subjected to oral tolerance, inferred by the suppression of antibody production (94).

Orally Administered Immunoprophylactics and the Implication in the Gut Immune System

Immunostimulants

Immunoregulators are environmentally friendly compounds safe for animal utilization and can modulate the immune status of the host, and thus make the animal able to cope with diseases (95, 96). Herbal medicines have drawn much attention recently and are often administered as feed additives using a whole plant or parts of a plant (e.g., leaves, fruits, seeds or root), the extracts of the plant or active compounds from the plant (97–99). Herbal compounds have been considered promising natural and effective growth promoters, antibacterial agents, and immunoprophylactic agents for finfish (100–103) and improve appetite and alleviate stress-mediated effects in fish (104). In the last few decades, investigation of the effectiveness of the application of herbal medicines as immunomodulators in aquaculture has been conducted to reduce the use of chemicals and antibiotics during production (105, 106). In fact, herbal medicine or plant extracts are rich in various biologically active substances with beneficial health properties, such as saponins, alkaloids, waxes, carotenoids, vitamin, terpenoids, tannic acid, organic acids, volatile oils, polysaccharides, glycosides, flavonoids, and others, are considered to benefit aquatic animals with improved growth and immune performance (107–110). Many studies have reported the enhancement of systematic immunological responses in a variety of fish species after ingestion of herbal plants (or their extracts), such as increased phagocytic activity, complement activity, the ability to generate reactive oxygen and nitrogen species, lysozyme activity, antiprotease activity, and expression of immune-related genes in the blood, head kidney, spleen and liver (111–115), but only a few reported local immune parameters in the MALT. In we summarized studies in these past five years focusing on the immune responses of the MALT and the increased resistance to pathogenic microbes in fish that were subjected to dietary phytotherapeutics of various doses and duration times. Studies have demonstrated that dietary supplementation of medical herbs can positively influence the intestinal structure and improve the functionality of the gut. For example, Zahran et al. (129) reported that oral administration of Withania somnifera, commonly known as “Indian ginseng” or “winter cherry”, at a inclusion level of 5%, improved the growth of Nile tilapia, possibly due to increased levels of digestive enzymes and absorptive surface of the intestine, as well as a higher number of goblet cells (GC) in the proximal and middle gut. An elevation in the villous width in the gut from Nile tilapia (Oreochromis niloticus) that ingested quinoa (Chenopodium quinoa) seeds and prickly pear fruit (Opuntia ficus indica) peel was reported by Ahmed et al. (118), and a higher number of GC counts in the intestine was observed in the 20% prickly pear fruit peel-supplemented group (118). Likewise, rainbow trout fed with grapevine (Vitis vinifera) seed extract had increased GC density and the number of intraepithelial lymphocytes in the intestine (128). GC, specialized epithelial cells play a vital role in delivering low molecular weight soluble antigens to dendritic cells in the lamina propria in the steady-state (as known as goblet-cell-associated antigen passages, GAP) in mammals (131, 132). Moreover, GCs are important in the generation of mucin which provides a thick mucus lining to the gut and protects the mucosal surface by trapping pathogenic microbes (133). A higher number of GCs was recorded in brown trout (Salmo trutta) intestine infected with the parasite (134) and in Nile tilapia, challenged with the bacteria Aeromonas sobria (118), suggesting a conserved protective role by the teleost GCs (5).
Table 1

Orally administrated herbs having modulatory activity on the gut immune system.

Source/form Fish species/Body weight (g)DosesDurationResultsResistance to pathogenReference
Agaricus bisporus/powder Cyprinus carpio (9.15 ± 0.09)0-2%8 weeksIntestine:Expression of gr and gstN.A. (116)
Aloysia citrodora/leave powder Oncorrhyncus myskiss (2.5 ± 0.1)0-2%6 weeksIntestine:Expression of il-1β, il-8 and tnf-α ↑, and tgf-β ↓, and il-10N.A. (117)
Chenopodium quinoa seed (QU) and Opuntia ficus indica peel (PP)/powder Oreochromis niloticus (21–25)0-20%45 daysIntestine:Pre challenge:Intestinal villi length –, villi width ↑, goblet cell count (group PP20 only) ↑Post challenge:Intestinal villi length and width and goblet cell count ↑ Aeromonas sobria (118)
Curcumin/extract Cyprinus carpio (16.37 ± 0.79)0-15 g/kg8 weeksIntestine:Expression of sod and nrf2 ↑, and CAT and hsp70 –;Expression of il-10 ↑, and il-1β, tnf-α and tlr22 ↓, and nf-κbp65N.A. (119)
Dioscorea opposita/powder Cyprinus carpio (75.19 ± 1.56)0-2%8 weeksIntestine:SOD, CAT and LYZ ↑;Total SCFA, AA, PA, BA ↑, and MDA –;MV height ↑, and muscular thickness (mid-gut) –;Expression of oc and zo-1 ↑;Expression of il-1β, tgf-β, tlr4 and nfκb ↑, and il-10 and tnf-α – (mid-gut)Higher relative abundances of Fusobacteria and Bacteroidetes, and lower relative abundances of Proteobacteria (e.g. Enterobacteriaceae, Shewanella, Pseudomonas and Vibrio) and ratio of Firmicutes/Bacteroidetes in fecal microbiomes; increased the diversity of the gut floraN.A. (120)
Ferula assafoetida/powder Cyprinus carpio (14.60 ± 1.29)0-2%8 weeksIntestine:Expression of lyz, tnf-α and il-1β ↑, and il-8N.A. (121)
Ginkgo biloba leaf/extract Epinephelus lanceolatus× Epinephelus fuscoguttatus(7.84 ± 0.35)0-10 g/kg8 weeksIntestine:SOD, CAT and T-AOC ↑, and MDA ↓;Expression of zo-1, -2, -3, oc and claudin 3a ↑ (lower conc.);Expression of il-8 (higher conc.), il-10 (lower conc.), tgf-β (lower conc.) and tor (lower conc.) ↑;Expression of gpx, cat and gr ↑ (lower conc.) and ↓ (higher conc.), but Keap1 ↓ (lower conc.) and ↑ (higher conc.);Expression of caspase 3, 8 and 9 ↓ (lower conc.) and ↑ (higher conc.)N.A. (122)
Ginkgo biloba leaf/extract Cyprinus carpio (7.84 ± 0.35)0-10 g/kg8 weeksIntestine:Expression of il-1β, il-8, tnf-α, il-10, tgf-β, inos, cox2 and arg ↓, and saa, hep, and gpx1 ↑, and sod –;SUR ↑ Aeromonas hydrophila (123)
Jasonia glutinosa/powder Sparus aurata L. (6.0 ± 0.8)0-30%15 and 30 daysIntestine:Expression of cat and sod ↑ in the PrI on day 15N.A. (124)
Prunus domestica/extract Oncorhynchus mykiss (27.61 ± 0.44)0-1%21 daysIntestine:Expression of il-10, il-6, il-8, il-12 and cox-2 ↑, and il-1β –;SUR ↑ Yersinia ruckeri (125)
Psidium guajava/leaf extract Oreochromis niloticus (1.32 ± 0.04)0-1%84 daysIntestine:Insignificantly increased villi height and width;SUR ↑ Aeromonas hydrophila (126)
Psidium guajava/leaf powder Cyprinus carpio (15.88 ± 0.27)0-1%8 weeksIntestine:Expression of il-1β and il-8 ↑, and tnf-αN.A. (116)
Silybum marianum L./extract Ctenopharyngodon idella (24.2 ± 0.1)0-100 mg/kg70 daysIntestine:InL, ILI, IW and ISI↑Mucosal permeability ↓Improved the intestinal histological pathological symptoms after infection;Expression of 9 TJ-related genes (zo-1, -2b, oc, jam-a, claudin-b, -c, -f, -3c, -11) ↑, and 2 (claudin-12 and -15a) ↓, and claudin-7a, -7b and -15b –;Expression of 5 AJC-related genes (e-cadherin, α-catenin, β-catenin, nectin, afadin) ↑;Expression of 4 AJC-related genes (rhoa, rock, mlck and nm-ii) ↓;GTP-RhoA protein levels ↓N. A. (127)
Vitis vinifera seed/extract Oncorhynchus mykiss (~ 1.3)0-200 mg/kg60 daysIntestine:Villus height (PrI, MI, DI) and width (PrI, DI) ↑,Tunica muscularis thickness, absorption surface area, villus density, acidic/neutral/mixed mucin goblet cells –Goblet cell density (PrI, DI) ↑,Number intraepithelial lymphocytes (PrI) ↑;Expression of c3, lyz and ifn-γ –, and β-defensin3, tnf-αN. A. (128)
Withania somnifera root/powder Oreochromis niloticus (45)0-5%60 daysIntestine:Diameter of lumen ↓ in the DI, and – in the PrI and MI;Number of mucosal folds: ↑ in the PrI, but ↓ in the MI and DI;Number of goblet cells: ↑ in the PrI and MI, but – in the DI;Mucosal folds height: – in the PrI, but ↑ in the MI and DI;Perimeter: – in the PrI and MI, but ↑ in the DI;Area within the perimeter for each fold: – in the PrI and MI, but ↑ in the DI;Width of lamina propria: ↑ in the PrI, MI and DI;Thickness of muscle: ↓ in the PrI, but –MI and DI Streptococcus iniae (only study the expression of cytokines in the head kidney and spleen) (129)
Yucca schidigera/extract Cyprinus carpio (45.21 ± 0.43)0-400 mg/kg8 weeksIntestine:T-AOC, C3, C4 and LYZ ↑, and MDA ↓, and total SOD and IgM –;Expression of zo-1, oc, claudin 11 ↑ (TJ genes), claudin -3 and -7 –;Expression of tgf-β2 ↑, il-10 –, and il-6, il-1β and tnf-α ↓ (inflammatory cytokine genes);Expression of CuZnsod, cat, gpx1a and nrf2 ↑, and keap1 ↓ (antioxidant genes);N.A. (130)
Orally administrated herbs having modulatory activity on the gut immune system. Few studies have evaluated the influence of dietary supplementation of medicinal plants on the expression of junctional genes in the intestine. Meng et al. (120) investigated the effects of oral administration of yam (Dioscorea opposita) peels to common carp (Cyprinus carpio) and found higher microvilli density and GC numbers as well as elevated transcript levels of tight junction (TJ)-related genes (occludin (oc) and zonula occludens-1 (zo-1) (118). Similar findings were also reported in common carp fed Yucca schidigera (known as the Mojave yucca or Spanish dagger) extract in the feed, with higher gene expression levels of zo-1, oc, and claudin 11 in the intestine after an 8-week feeding trial (130). In hybrid grouper (Epinephelus lanceolatus ♂ × E. fuscoguttatus ♀), zo-1, -2, -3, oc and claudin 3a were induced in the gut when fed with high lipid diets supplemented with Ginkgo biloba (maidenhair tree) leaf extract (122). Dietary supplementation with silymarin (extracted from Silybum marianum L.) improved the growth of juvenile grass carp possibly owing to promoted intestinal histology (127). Moreover, ingestion of silymarin induced transcript levels of barrier-forming tight junction (TJ)- and adherent junction (AJ)- related genes accompanied by the reduced expression of pore-forming TJ genes by inhibiting a small Rho GTPase protein (RhoA) and/Rho-associated protein kinase (ROCK) signaling pathway in the gut, indicating that silymarin treatment could enhance intestinal apical junctional complex (AJC) integrity by strengthening TJ and AJ. (127). These findings indicate that supplementation of certain herbal medicines can improve the growth of fish and equally important, strengthen the immune status of the gut. Cytokines can be categorized into proinflammatory cytokines (e.g., IL-1β, IL-8, TNF-α, and IL-6) and anti-inflammatory cytokines (e.g., IL-10 and TGF-β) (130, 135). Cytokines are crucial for regulating multiple aspects of the immune response. Thus, they have been monitored to predict changes in the gut immunity. Studies have shown the anti-inflammatory effects in the gut after the use of herbal medicinal products. TGF-β1 and IL-10 are immunosuppressive cytokines that restrain inflammation by decreasing the production of inflammatory cytokines (135). Significantly downregulated mRNA expression of proinflammatory cytokines (e.g., il-1β and tnf-α) and upregulation of anti-inflammatory cytokines (e.g., il-10 and tgf-β) were observed in the intestine of common carp after 8 weeks of curcumin administration (119), Yucca schidigera extract (130) and Ginkgo biloba leaf extract (123). Similarly, hybrid groupers fed Ginkgo biloba leaf extract also exhibited higher expression of il-10 and tgf-β in the intestine (122). However, the opposite expression pattern of cytokines in herbal medicine treated fish has also been reported. Increased transcript levels of proinflammatory cytokines were reported in the intestine of common carp with Psidium guajava (guava) leaf powder (116), Dioscorea opposita (chinese yam) powder (120) or Ferula assafoetida (asafetida) powder (121), and rainbow trout with Aloysia citrodora (lemon verbena) leave powder (117) or Vitis vinifera seed extract (128). IL-1β is an effector in the inflammatory responses expressed by distinct cell populations after the activation of pattern recognition receptors (PRRs) once triggered by an invading pathogen. IL-6 is known to play a major role in haematopoiesis e.g. promoted macrophage growth (136), and is with biphasic pro-and anti-inflammatory properties (135). IL-8 is a chemokine for attracting neutrophils, monocytes, basophils, T cells, and eosinophils (135). TNF-α, with overlapping functions with IL-1β, is an immune gene expressed in the early phase of infection and has a key role in regulating inflammation (135). However, TNF-α can activate NADPH oxidase, which leads to the generation of reactive oxygen species (ROS) that may promote inflammation by activating inflammasomes and the release of mature IL-1β and IL-18 cytokines (137–139), as well as serving as second messengers to control the action of several signaling pathways (140). Therefore, an increased expression level of inflammatory cytokines in the intestine can have negative health effects for fish (141).

Vaccines and Adjuvants

Vaccination is one of the essential and powerful prophylactic means of infectious disease control that can provoke immune memory and reduce the need for antibiotics in aquaculture (142). Many types of vaccines have been developed with different ways of introduction, including spray, oral, immersion and injection. Although injectable vaccines have been proven to be effective, some critical limitations such as the requirement of high labor demand, trauma on the skin at the injection site that may cause secondary infection, fish size at vaccination and handling stress to the fish, have also been noticed (143). Oral immunization can circumvent the aforementioned disadvantages; therefore, is now an important topic under investigation (13). However, there are still some obstacles that require solutions to achieve high efficacy of oral vaccines (77). The antigens in a vaccine may be broken down and inactivated in the gastrointestinal tract before reaching the intestinal mucosa and activating immune cells (144). The availability of antigens will thus be lowered, and a low antigen dose will induce regulatory T-cell-mediated immune tolerance (92). To protect the antigens from gastric degradation, several encapsulation techniques such as using alginate microparticles, virus-like particles (VLPs), chitosan, liposomes, immunostimulating complexes (ISCOMs) and poly (D, L-lactic-co-glycolic acid) (PLGA) have been developed and summarized previously (92, 145, 146). ISCOMs are formulated by the mixing of; amphipathic antigen, the saponin-based adjuvant Quil-A, and cholesterol in a 1:1:1 ratio (147). ISCOM technology-based Matrix M™ adjuvant has been studied in a range of veterinary vaccines and has the potential to be commercialized (147). In terms of antigen production, subunit antigens are particularly of interest since they can be produced using various protein expression systems and are safe to the host given the fact that they do not possess live components of the pathogen (148). Escherichia coli (E. coli) (149) and yeast (150, 151) are two of the most widely used protein expression systems for the production of subunit antigens in fish vaccinology (92), but recent studies have also shown the potential of using other enteric probiotics as vaccine vehicles. Choosing the right enteric probiotic as a vaccine vehicle is important as fish gastrointestinal mucus dissociates microbes and is constantly sloughed off and replaced. The transient availability or low doses of vaccine immunogens in the inductive site of the gastrointestinal tract will result in poor antigen uptake by the GALT and thus diminish the success rate of immunization. Generally regarded as safe (GRAS) is a United States Food & Drug Administration (FDA) designation stipulates that any substance that is intentionally added to food is generally considered safe by qualified experts. Lactic acid bacteria (LAB), e.g. Lactococcus and Lactobacillus (152) and Bacillus subtilis (153) are recognized as probiotics, which are GRAS to fish and thus can be used as an oral vaccine vehicle to present antigen ( ). LAB not only can colonize and persist in the gastrointestinal tract, but with prospective applications such as modulating the host immune system, competing with pathogens for mucosal binding sites, promoting digestive function, improving the disease resistance of the host, delivering expression DNA and antigen presentation to mucosal tissue of the host (152, 154, 170, 171).
Table 2

Oral vaccines and the feeding regimes.

Source/formFish species/Body weight (g)DosesFeeding regimeResultsResistance to pathogenReference
Lactococcus lactis BFE920 expressing Edwardsiella tarda OmpA, FlgD, or a fusion antigen of the two Paralichthys olivaceus (86.36 ± 4.31)~0.8-1.4 × 107 CFU/gTwice with a one-week intervalIntestine:Expression of T cell responses (cd4-1, cd4-2, cd8-α, t-bet, ifn-γ) ↑Expression of tlr5m, il-1β and il-12p40SUR ↑ after being challenged at 4th week Edwardsiella tarda (142)
Lactococcus lactis expressing the G gene from VHSV Oncorhynchus mykiss (7 ± 0.65)1.0 × 1010 CFU/g and 1.0 × 108 CFU/gVaccination was conducted on day 1–7 and day 15–21SUR ↑ after being challenged on day 60 post vaccinationVHSV (154)
Lactococcus lactis expressing HIRRV-glycoprotein (G) on the cell surface Paralichthys olivaceus (35 ± 5)1.0 × 109 CFU/g dietVaccination was conducted at week 1 and week 5Intestine:IgM against HIRRV ↑ in the gut mucusSUR ↑ after being challenged at 8th weekHIRRV (155)
Lactococcus lactis BFE920 expressing OmpK and FlaB Paralichthys olivaceus Juvenile (7.1 ± 0.8 g) and adult (140 ± 10 g)1 × 107 CFU/g feedVaccination was conducted for 1 week with a 1-week interval, repeating three timesIntestine:Expression of T cell responses (cd4-1, cd4-2, cd8-α, t-bet, ifn-γ) ↑Expression of tlr5m, il-1β and il-12p40SUR ↑ after being challenged at 7th week Vibrio anguillarum, Vibrio alginolyticus, and Vibrio harveyi (156)
Lactobacillus casei expressing the fusion protein of OmpI from A. veronii TH0426 and C5 – I from common carp (surface-displayed or secreted) Carassius carassius (50.00 ± 1.00 g)~1.0 × 109 CFU/g feedVaccination was conducted on days 1–3 (prime vaccination), 18–20 (booster vaccination) and 34 (challenge)Intestine:Expression of il-1β, il-10, ifn-γ and tnf-α ↑post vaccinationSUR ↑ after being challenged on day 34 Aeromonas veronii (157)
Lactobacillus casei strain expressing Malt from Aeromonas veronii TH0426 Cyprinus carpio (65 ± 4)~1.0 × 109 CFU/g feedVaccination was conducted on days 0–2 (prime vaccination), 14–15 (booster vaccination) and 34 (challenge)Intestine:Expression of il-1β, il-10, ifn-γ and tnf-α ↑post vaccinationSUR ↑ after being challenged on day 34 Aeromonas veronii (158)
Lactobacillus casei expressing the OmpW of A. veronii (surface-displayed or secreted) Cyprinus carpio (56 ± 1)1.0 × 109 CFU/g feedVaccination was conducted on day 1–3 and on day 18–20Intestine:Expression of the il-1β, il-10, ifn-γ and tnf-α ↑ post vaccinationSUR ↑ after being challenged on day 34 after the boost immunization Aeromonas veronii (159)
Lactobacillus casei expressing the FlaB of A. veronii (surface-displayed or secretory) Cyprinus carpio (56 ± 1)2.0 × 109 CFU/g feedVaccination was conducted on day 0–2 and on day 28–29Intestine:Expression of the il-1β, il-10, ifn-γ and tnf-α ↑ post vaccinationSUR ↑ after being challenged on day 58 after immunization Aeromonas veronii (160)
Lactobacillus casei expressing the OmpAI of A. veronii (surface-displayed or secretory) Cyprinus carpio (50 ± 1)2.0 × 109 CFU/g feedVaccination was conducted on day 1 and on day 32Intestine:Expression of the il-1β, il-10, ifn-γ and tnf-α ↑ post vaccinationSUR ↑ after being challenged on day 66 after immunization Aeromonas veronii (161)
Lactobacillus casei expressing CK6-VP2 fusion protein Oncorhynchus mykiss (11.5)2 × 109 CFU/fishVaccination was conducted on days 1 and 32Intestine:Expression of β-defensinSkin mucus:Titer of anti-VP2 IgT ↑IPNV (162)
Lactobacillus casei expresses the AHA1-CK6-VP2 fusion protein Oncorhynchus mykiss (~ 10)200 μl of recombinant strainsOrogastric intubation was conducted on days 1, 2 and 3, and boost on days 31, 32, and 33Intestine:The colonization ability of pPG-612-AHA1-CK6-VP2/L. casei 393 was higher than other groups on day 3 and 7Skin mucus:Titer of anti-VP2 IgT ↑IPNV (144)
Lactobacillus rhamnosus expresses the ORF81 from CyHV3 Cyprinus carpio (~ 50)5.2 1010 CFU/g feedVaccination was conducted on day 1-3, day 14-16 (booster vaccination) and day 28-30 (booster vaccination)SUR ↑ after being challenged on day 15 after the second boosterCyHV3 (163)
Bacillus subtilis spores displaying the VP7 of GCRV Ctenopharyngodon idella (50 ± 5)1.0 × 1010 spores/fishVaccination was conducted on day 1 and day 8SUR ↑ after being challenged on day 14 after the boost immunizationGCRV (164)
Bacillus subtilis spore expressing the VP4 of GCRV Ctenopharyngodon idellus (23 ± 2)2.3 × 1011 spores/fish/day, amount to 1 × 10−3 μg/g (protein/fish)Vaccination was conducted daily for 8 weeksIntestine:Lower GCRV viral load in intestineHigher anti-GCRV IgZ titer in the intestinal mucusExpression of csf1r, mhc-ii, cd8 and il-1βSUR ↑ after being challenged on week 10GCRV (165)
Bacillus subtilis GC5 expressing the Sip of S. agalactiae on the surface Oreochromis niloticus (22 ± 2)109 CFU/100 μL/fishVaccination was conducted once on week 0 and once on week 3Intestine:Expression of tp3, tnf-α, il-1β, tgf-β, il-10, mhc-i, mhc-ii, cd4, cd8, tcr-β, igm and t-bet were differentially modulated post vaccinationSUR ↑ after being challenged on week 6 post-vaccination Streptococcus agalactiae (166)
Yeast expressing the OmpG and Omp48 of A. hydrophila Carassius auratus (~6)1.5 × 108 heat-killed yeast cells/g meal powderVaccination was conducted daily for 4 weeksSUR ↑ after being challenged on day 28 Aeromonas hydrophila (150)
Saccharomyces cerevisiae expressing ORF131 of CyHV-3 on the cell surface Cyprinus carpio var. Jian(~10)1.6 × 109 CFU yeast in 300 μL PBSVaccination was conducted 3 times at a 2-week intervalSUR ↑ after being challenged at four weeks post the third immunizationCyHV-3 (151)
Rootless duckweed (Wolffia) expresses LamB from Vibrio alginolyticus Danio rerio (N.A.)N. A.Vaccination was conducted for 60 days from month 0-2 and boost for 30 days on month 3-4SUR ↑ after being challenged six weeks post-vaccination (booster) Vibrio alginolyticus (167)
Tobacco leaves express RGNNV- capsid protein Epinephelus septemfasciatus (25.8 g)200 μg/fishVaccination was conducted once a day for five consecutive daysSUR ↑ after being challenged on day 21 after immunizationRGNNV (168)
Escherichia coli expressing the capsid protein of NNV Dicentrarchus labrax (10–12)1010 CFU/g dietVaccination was conducted 3 consecutive days and a boost at day 14SUR ↑ after being challenged at 30 days post vaccinationNNV (149)
Tobacco expressing the capsid protein of NNV Hyporthodus septemfasciatus (N.A.)5 µg or 10 µg plant-derived recombinant coat proteinVaccination was conducted every Monday at 2-week intervals for a total of 4 timesSUR ↑ after being challenged at six days after the final immunizationNNV (169)
Oral vaccines and the feeding regimes. Lactococcus lactis is a widely used bacterium and is a prominent candidate to develop oral vaccines and host-vector, since it possesses several advantages, such as: absence of endotoxins and biogenic amine production, and ability to be cultured in chemically defined media, it can be genetically manipulated, the genome sequence is readily available and is considered to have a safe profile for use in the development of vaccine formulations (154, 172–174). Successful examples of immunization and induction of protection of fish using Lactococcus lactis-expressing antigen(s) from Edwardsiella tarda (outer membrane protein (Omp)A and flagellar hook protein (Flg)D) (142), viral hemorrhagic septicemia virus (VHSV) (154), and hirame novirhabdovirus (HIRRV) (155) have been reported. These studies demonstrated that the immunization elicited higher expression of T cell markers and proinflammatory genes in the intestine (142) and higher survival rate relative to the control group in the challenge assay a few weeks post-vaccination. Interestingly, a recent study showed that oral immunization of olive flounder (Paralichthys olivaceus) with Lactococcus lactis BFE920 that express fusion antigens of OmpK from Vibrio anguillarum and flagellin B subunit (FlaB) from Vibrio alginolyticus increased the levels of serum antigen-specific antibodies and expression of cytokines and T cell markers in the intestine. It is important to highlight that the same study revealed the universal protective effects of the vaccine to fish from multiple strains of Vibrio pathogens, namely Vibrio anguillarum, Vibrio alginolyticus, and Vibrio harveyi, even though the vaccine did not contain specific antigens from Vibrio harveyi. The cross-protection against Vibrio harveyi may happen due to the high homologies in protein sequences and structures of the OmpK and FlaB among the three Vibrio species, which then rendered in immunological cross-reactivity via shared epitopes (156). Therefore, comprehensive antigen mapping is encouraged for developing universal vaccines in fish with high protection. The literature accumulates evidence that Lactobacillus casei is also a prominent live vehicle for expressing and transporting heterologous antigens to mucosal sites. For example, the recombinant Lactobacillus casei can be detected in the digestive tract of common carp following oral administration, and colonization was shown to be higher in the hind-gut than in the prosogaster and mid-gut (158–161). Meanwhile, these studies also showed that oral vaccination of common carp with Lactobacillus casei (1-2 × 109 CFU/g feed) displaying antigen(s) (surface-displayed or secreted) from Aeromonas veronii resulted in elevated transcript level of immune genes in the intestine post-vaccination and provided strong protection for common carps against this pathogenic bacteria (158–161). Immunization of crucian carp (Carassius carassius) with recombinant Lactobacillus casei that expresses a fusion protein encoded by of OmpAI gene from Aeromonas veronii and chemokine c5 – i gene (served as a molecular adjuvant) from common carp resulted in enhanced alkaline phosphatase, superoxide dismutase and acid phosphatase in the serum and higher expression of il-10, il-1β, tnf-α, and ifn-γ in the heart, liver, spleen, head kidney, and intestinal tract. More importantly, recombinant Lactobacillus casei provided strong protection (survival rate at least 60% versus 0% for the unimmunized control group) against A. veronii infection (157). Additionally, Lactobacillus casei was proven to be able to express a fusion protein (VP2-CK6) of a viral gene (VP2) from infectious pancreatic necrosis virus (IPNV) and a chemokine (CK6) gene from rainbow trout that can induce leukocyte migration, inflammatory responses and killing the target cells (162). Orally vaccinated fish exhibited induced expression of β-defensin in the intestine, higher anti-VP2 IgT titer in the skin mucus and lower viral load in the liver and pancreas compared to the control group (162). To further boost the effects of this oral vaccine, a genetically engineered Lactobacillus casei was constructed to present the Aeromonas hydrophila adhesion (AHA1) -CK6-VP2 fusion protein (144). Recombinant AHA1 protein was illustrated to adhere to epithelial cells possibly due to its strong hydrophobicity that can bind to the cell surface receptor via covalent bonds (175). Intestinal colonization and the ability to induce specific anti-IPNV-specific IgT and IgM antibodies were found to be higher in the fish that had AHA1-CK6-VP2 expressed Lactobacillus casei than other groups (including the Lactobacillus casei that displayed VP2-CK6 recombinant protein), indicating that AHA1 helped in antigen retention in the intestinal tract and enhance the immunogenicity of the LAB vaccine (144). The utilization of probiotic vaccines provided a certain tolerance to harsh conditions in the gastrointestinal tract. However, better cell viability of probiotics during passing through the gastrointestinal tract would improve their efficacy. For example, oral immunization of Koi carp (Cyprinus carpio) with chitosan-alginate encapsulated live recombinant Lactobacillus rhamnosus expressing ORF81 protein from cyprinid herpesvirus 3 (CyHV-3) provided elevated antigen-specific IgM production in the serum and antigen-specific IgM-secreting cells in the spleen (163). A higher survival rate was noted for the fish orally vaccinated with the encapsulated live probiotic vaccine than that of fish fed with the vector-containing probiotic control group after CyHV-3 challenge (163). However, it is worth mentioning that a comparison of recombinant probiotic vaccines containing specific antigens (ORF81 in this case) with or without encapsulation would provide valuable information on the efficacy of encapsulation. The spores of Bacillus subtilis can withstand wet heat, desiccation and tolerate acid conditions. Additionally, B. subtilis spores exhibit the potent adjuvant property that can benefit by inducing the protective immune responses and minimizing tolerance (176), which makes it an ideal antigen producing and delivering system for the fish oral vaccine (165, 166). Research has demonstrated that oral vaccination of grass carp (Ctenopharyngodon idella) with the engineered B. subtilis spores that express VP7 (164) or VP4 (165) from grass carp reovirus (GCRV) on the spore surface could provide adequate immunity against GCRV infection; although, the challenge assay, in these two studies, was assessed for a very short time (14 days) following the last vaccine administration. These works highlighted a novel strategy of applying LAB and Bacillus subtilis spores, two powerful and efficient expression systems as oral vaccine delivery vehicles, which confer high immunogenicity and sufficient protection against microbial infection. An adjuvant is purported to be crucial in improving immunogenicity and prolonging the duration of protection of a mucosal vaccine (177). Choosing the right combination of adjuvant and vaccine candidates will balance and circumvent oral tolerance (145). Aluminum hydroxide and oil-based adjuvants are the most commonly used adjuvants in injectable vaccination of aquaculture due to their high efficacy and low production cost (178). These adjuvants are less commonly used in oral vaccine studies as they can result in local negative effects such as necrosis and tissue inflammation (145). Recombinant cytokines are gaining popularity as the ideal mucosal adjuvants as they do not induce necrosis. Although synthetic cytokines have been long applied as an adjuvant in the injectable vaccine in aquaculture, the first fish study that evaluated the recombinant cytokine as an oral adjuvant was reported by Galindo-Villegas et al. (179). By incorporating recombinant TNF-a with a commercial oral vaccine of V. anguillarum, higher immunostimulatory responses including il-1β, lysozyme and IgT production were recorded in the adjuvant group relative to the non-adjuvanted group (179). Other pro-inflammatory cytokines such as IL-12 and IFN-γ have been proposed to be potential oral vaccine adjuvants (145). Plants have been applied as bioreactors to produce biopharmaceuticals including antigens for vaccines, growth factors, antibodies, and cytokines (180). With thick and rigid cell walls, transgenic plants are regarded as one of the ideal solutions for antigen generation and protection simultaneously (167). Additional advantages such as cost-effectiveness, high scalability, and low risk of contamination by bacterial components (e.g. endotoxins) are also proposed for plant molecular farming (180). Feeding zebrafish with rootless duckweed (Wolffia globosa) expressing LamB (maltoporin) from Vibrio alginolyticus resulted in high relative percent survival (RPS) of the vaccinated fish (63.3%) from Vibrio infection (167). Similarly, oral administration of the crudely purified protein extract containing chloroplast-derived red-spotted grouper NNV (RGNNV) virus-like particle (VLP) provided comparable protection compared to a commercial injectable vaccine in the sevenband grouper fish against RGNNV challenge (168).

Challenges and Future Perspectives

Despite the growing number of oral prophylactics being reported, the lack of consistency in performance, particularly on-site farm testing, and the limited successful application remain pressing issues (181). As the most diverse and largest vertebrate groups (182), fish display high heterogeneity in their physiology and immune system (38). For instance, the gadoid species do not possess CD4 (53) and MHC molecules (53, 183) compared to the other finfish species. Anatomically, cultured finfish can be differentiated as gastric and agastric species, which differ significantly in the morphology and structure of their gastrointestinal tract (38). As mentioned earlier, the nomenclature applied for dividing the intestine in fish has been inconsistent. These aforementioned factors have driven the divergence in the findings of fish gut immunity. The functionality and underlying mechanistic details of some GALT immune components, viz. teleost IgD, remains obscure. Immunological studies of fish are slower than those of their mammalian counterparts. Furthermore, insights derived from mammalian immune studies may not be applicable to aquaculture. CD8-α+, a signature receptor of mammalian cytotoxic T-cells have been reported to be expressed by fish dendritic cells beside cytotoxic T-cells (79). The lack of specific cellular biomarkers to differentiate leukocyte subpopulations in many aquaculture species impedes the understanding of the gut immune system in higher resolution (184). Even though teleost fish were the first vertebrate animals to start presenting the classic adaptive immunological features, their antibody isotypes are more limited and primitive compared to other animals on the upper scale of the evolutionary tree (185); Thus, their adaptive immunological responses are not as effective as other farmed livestock species like poultry, swine or cattle, and the immunological memory might not be long-lasting. In addition, fish gut possesses intricate GALT and a harsh gastrointestinal environment to fend off the microbial intrusion, but it also greatly reduces the uptake of the immunoprophylactics at the induction site (38). To provoke the desired bioactivity and prevent oral tolerance, the research and development of oral immunoprophylactics must address several necessities, such as a substantial amount of antigen, proper encapsulation or vector and a well-designed feeding regime (38). To elicit long-lasting protection, there are trade-offs between repetitive immunizations via booster and the risk of getting anergy-mediated immune suppression. In addition to these challenges, the design and technology of the orally administered end prophylactics should be cost-effective to prevent overtaxing aquaculture production costs. Aquaculture practices worldwide are generating a diverse range of finfish species. These species of finfish evolved differently, in which the developmental biology of these cultured finfish can have particularities. The differences in phenotype, biological processes and responses, and molecular functions are associated with the control and regulation at the molecular level, where the epigenome can play role. Thus, research findings from the study of one finfish species do not always translate to another species. Therefore, extensive study of various aspects, which include the fundamental immunology and functional characterization; physiology; biomarker development; and the optimization of the feeding regime as well as rearing conditions are necessary for each species of interest.

Author Contributions

P-TL shares the first authorship. FY and C-FL have contributed equally to this work. J-YL and C-MC share the last and corresponding authorship. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
AAacetic acid
AHA1 Aeromonas hydrophila adhesion
AJCapical junctional complex
ARGarginase
BAbutyric acid
C3Complement 3
C4Complement 4
CATcatalase
CDcluster of differentiation
CFUcolony forming unit
CK6Chemokine 6
COXcyclooxygenase
CSF1Rcolony-stimulating factor 1 receptor
CuZnSODcopper zinc superoxide dismutase
CyHV-3Cyprinid Herpesvirus 3
DIdistal intestine
flaBflagellin B
FlgDflagellar hook protein D
GALTgut-associted lymphoid tissues
GCRVgrass carp reovirus
GPxglutathione peroxidase
GRglutathione reductase
GSTglutathione S-transferases
HEPhepcidin
HIRRVHirame novirhabdovirus
HSPheat shock protein
IELintraepithelial lymphocyte
IFNinterferon
Igimmunoglobulin
ILinterleukin
ILIintestinal length index
InLintestinal length
iNOSinducible nitric oxide synthase
IPNVInfectious pancreatic necrosis virus
ISIintestinal somatic index
IWintestinal weight
JAM-Ajunctional adhesion molecule-A
Keap1Kelch-like- ECH-associated protein 1
LambLambda B
LPSlipopolysaccharides
LYZlysozyme
MDAmalondialdehyde
MHCmajor histocompatibility complex
MImiddle intestine
MLCKmyosin light chain kinase
MVmicrovillus
N.A.Not available
NFκBnuclear factor kappa B
NMIInon-muscle myosin II
NNVNerve necrosis virus
Nrf2nuclear factor erythroid 2–related factor 2
OCoccluding
Ompouter membrane protein
ORF131open reading frame 131
PApropionic acid
PBSphosphate buffered saline
PP20prickly pear fruit peel-supplemented group (20%)
PrIproximal intestine
RGNNVred-spotted grouper nervous necrosis virus
RhoAa small Rho GTPase protein
ROCKthe Rho associated protein kinase
SAAserum amyloid A
SCFAshort chain fatty acids
Sipsurface immunogenic protein
SODsuperoxide dismutase
SURsurvival rate
T-AOCtotal antioxidant capacity
T-betT-box expressed in T cells
TCR-βT-cell receptor β chain
TGFtransforming growth factor
TJtight junction
TLRtoll-like receptor
TLR5Mmembrane form of TLR5
TNFtumor necrosis factor
TORtarget of rapamycin
TP3Tilapia piscidin 3
TRγδT-cell receptors of the γδ heterodimers
VHSVviral haemorrhagic septicaemia virus
VP2viral protein 2
ZOzonula occludens
  151 in total

1.  Effect of Yucca schidigera extract on the growth performance, intestinal antioxidant status, immune response, and tight junctions of mirror carp (Cyprinus carpio).

Authors:  Liansheng Wang; Di Wu; Ze Fan; Hongqin Li; Jinnan Li; Yuanyuan Zhang; Qiyou Xu; Guanghua Wang; Zhengpeng Zhu
Journal:  Fish Shellfish Immunol       Date:  2020-05-16       Impact factor: 4.581

2.  Construction and immune efficacy of recombinant Lactobacillus casei strains expressing Malt from Aeromonas veronii.

Authors:  An-Qi Ju; Shu-Bao Yang; Hai-Peng Zhang; Xin Ma; Dong-Xing Zhang; Yuan-Huan Kang; Qiu-Mei Shi; Tong-Lei Wu; Gui-Qin Wang; Ai-Dong Qian; Xiao-Feng Shan; Wei-Min Luan
Journal:  Microb Pathog       Date:  2020-01-11       Impact factor: 3.738

3.  Dietary supplementation of lemon verbena (Aloysia citrodora) improved immunity, immune-related genes expression and antioxidant enzymes in rainbow trout (Oncorrhyncus mykiss).

Authors:  Seyed Hossein Hoseinifar; Meysam Shakouri; Hien Van Doan; Shafigh Shafiei; Morteza Yousefi; Mojtaba Raeisi; Samira Yousefi; Ramasamy Harikrishnan; Miriam Reverter
Journal:  Fish Shellfish Immunol       Date:  2020-02-04       Impact factor: 4.581

4.  Dietary supplementation of olive leaf extract increases haematological, serum biochemical parameters and immune related genes expression level in common carp (Cyprinus carpio) juveniles.

Authors:  Fahriye Zemheri-Navruz; Ümit Acar; Sevdan Yılmaz
Journal:  Fish Shellfish Immunol       Date:  2019-04-13       Impact factor: 4.581

Review 5.  Goblet cells: multifaceted players in immunity at mucosal surfaces.

Authors:  Kathryn A Knoop; Rodney D Newberry
Journal:  Mucosal Immunol       Date:  2018-06-04       Impact factor: 7.313

6.  Differential immune responses of immunoglobulin Z subclass members in antibacterial immunity in a zebrafish model.

Authors:  Jian-Fei Ji; Chong-Bin Hu; Tong Shao; Dong-Dong Fan; Nan Zhang; Ai-Fu Lin; Li-Xin Xiang; Jian-Zhong Shao
Journal:  Immunology       Date:  2020-10-14       Impact factor: 7.397

7.  Ensuring safety of DNA vaccines.

Authors:  Jacob Glenting; Stephen Wessels
Journal:  Microb Cell Fact       Date:  2005-09-06       Impact factor: 5.328

Review 8.  Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts.

Authors:  K Szatraj; A K Szczepankowska; M Chmielewska-Jeznach
Journal:  J Appl Microbiol       Date:  2017-04-04       Impact factor: 3.772

9.  Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon.

Authors:  K A Knoop; K G McDonald; S McCrate; J R McDole; R D Newberry
Journal:  Mucosal Immunol       Date:  2014-07-09       Impact factor: 7.313

Review 10.  Oral Vaccination of Fish - Antigen Preparations, Uptake, and Immune Induction.

Authors:  Stephen Mutoloki; Hetron Mweemba Munang'andu; Øystein Evensen
Journal:  Front Immunol       Date:  2015-10-19       Impact factor: 7.561

View more
  2 in total

Review 1.  Phytocompounds as an Alternative Antimicrobial Approach in Aquaculture.

Authors:  Naqiuddin Nik Mohamad Nek Rahimi; Ikhsan Natrah; Jiun-Yan Loh; Francis Kumar Ervin Ranzil; Madi Gina; Swee-Hua Erin Lim; Kok-Song Lai; Chou-Min Chong
Journal:  Antibiotics (Basel)       Date:  2022-03-31

2.  Dietary Supplementation of a Commercial Prebiotic, Probiotic and Their Combination Affected Growth Performance and Transient Intestinal Microbiota of Red Drum (Sciaenops ocellatus L.).

Authors:  Fernando Y Yamamoto; Matthew Ellis; Paul R Bowles; Blaine A Suehs; Pedro L P F Carvalho; Caitlin E Older; Michael E Hume; Delbert M Gatlin
Journal:  Animals (Basel)       Date:  2022-09-30       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.